These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 1333302)

  • 1. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
    Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S
    Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
    Parker RI; Gralnick HR
    Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
    Chow TW; Hellums JD; Moake JL; Kroll MH
    Blood; 1992 Jul; 80(1):113-20. PubMed ID: 1611079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.
    DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P
    Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN; Colman RW
    J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
    Coller BS
    J Clin Invest; 1985 Jul; 76(1):101-8. PubMed ID: 2991335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet fibrinogen receptor.
    Peerschke EI
    Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential ability of agonists to express distinct pools of fibrinogen (GpIIb/IIIa) receptors which can mediate the aggregation of human platelets.
    Watts IS; Keery RJ; Lumley P
    Thromb Haemost; 1989 Nov; 62(3):955-61. PubMed ID: 2512682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
    Gralnick HR; Williams SB; Coller BS
    Blood; 1984 Oct; 64(4):797-800. PubMed ID: 6236859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
    Cox AD; Devine DV
    Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.
    Soslau G; Class R; Morgan DA; Foster C; Lord ST; Marchese P; Ruggeri ZM
    J Biol Chem; 2001 Jun; 276(24):21173-83. PubMed ID: 11283012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.